WilmerHale Advises Thermo Fisher on $1.2B USD and €1.25B EUR Notes Offerings

WilmerHale Advises Thermo Fisher on $1.2B USD and €1.25B EUR Notes Offerings

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
We guide clients through today’s ever-changing debt markets, representing them in a broad variety of debt deals that range from complex financial structures to traditional loan transactions.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale represented Thermo Fisher Scientific Inc. in connection with its public offering of €500.0 million aggregate principal amount of 3.200% Senior Notes due 2026 and €750.0 million aggregate principal amount of 3.650% Senior Notes due 2034 and its public offering of $600.0 million aggregate principal amount of 4.800% Senior Notes due 2027 and $600.0 million aggregate principal amount of 4.950% Senior Notes due 2032. Both offerings were priced on November 14, 2022 and closed on November 21, 2022. Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and Merrill Lynch International acted as representatives of the underwriters for the Eurobond offering and BofA Securities, Inc., Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. acted as representatives of the underwriters for the US dollar-denominated offering.

The WilmerHale legal team advising Thermo Fisher Scientific Inc on both offerings consisted of Erika Robinson, Justin Ochs, Molly Fox, Timothy Silva, Julie Hogan-Rodgers, Andrew Langworthy, Ryan S. Brewer, Ryan Lombardo, Ben Lobley and Mazen Osman.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel